Impact Events
Exascale Labs Holdings Inc. Completes Business Combination with Legacy Exascale
Exascale Labs Holdings Inc. (XLAB) announced the completion of its business combination with Legacy Exascale on August 27, 2026. The transaction involved a domestication merger and an acquisition merger, resulting in Exascale Labs Holdings Inc. succeeding to the business of Legacy Exascale. The company's Class A Common Stock and warrants commenced trading on Nasdaq under the symbols "XLAB" and "XLABW". Exascale Labs Holdings Inc. operates as a next-generation AI infrastructure provider with an asset-light, software-defined GPU compute platform and related AI infrastructure solutions.
Ferrari Buys Back 82,524 Shares for €29.8M in Early September
Ferrari N.V. reported on its ongoing share buyback program, detailing purchases made between September 21-25, 2026, as part of the third tranche of its multi-year program. The company acquired a total of 82,524 common shares across Euronext Milan and the New York Stock Exchange during this period. Year-to-date, Ferrari has repurchased 1,915,773 shares for a total consideration of over €587 million. As of September 25, 2026, the company held approximately 1.02% of its issued common shares in treasury.
Hudbay Extends Snow Lake Mine Life to 18 Years, Boosts Gold Output
Hudbay Minerals Inc. has updated its mine plan for its Snow Lake operations, extending the reserve mine life to 18 years and increasing total life-of-mine gold production by 60% to 2.8 million ounces. The company also raised its five-year average annual gold production forecast by 37% to 185,000 ounces. These enhancements are driven by increased mineral reserves and resources, progress on the 1901 deposit, and the identification of the Britannia Gold Project as a potential new anchor deposit.
HSBC Holdings to Redeem $2.5B Senior Unsecured Notes Due 2027
HSBC Holdings plc has issued a notice of redemption for its US$2,500,000,000 2.251% Fixed Rate/Floating Rate Senior Unsecured Notes due 2027. The redemption will occur in whole on November 22, 2026, with the payment date being November 23, 2026. Holders will receive the principal amount of US$1,000 per US$1,000 principal amount, along with accrued interest from May 22, 2026, to November 22, 2026.
SPDR Gold Trust Sponsor Appoints Joan A. Binstock to Board
World Gold Trust Services, LLC, the sponsor of SPDR® Gold Trust, has appointed Joan A. Binstock to its Board of Directors and Audit Committee, effective September 28, 2026. Ms. Binstock, 72, brings a wealth of experience from her advisory role at Lovell Minnick Partners and previous executive positions, including CFO at Lord, Abbett & Co. LLC. Her diverse board experience spans various financial institutions and investment funds.
World Gold Trust Sponsor Appoints Joan A. Binstock to Board and Audit Committee
WGC USA Asset Management Company, LLC, the sponsor of World Gold Trust, has appointed Joan A. Binstock to its Board of Directors and Audit Committee, effective September 28, 2026. Ms. Binstock, a CPA, brings a wealth of experience from her previous roles as CFO at Lord, Abbett & Co. LLC and COO at Morgan Grenfell Asset Management, among other senior positions at financial institutions. She currently holds board positions at several other investment funds and organizations.
Franklin Wireless Shifts Strategy Amidst Declining Sales and Increased Losses
Franklin Wireless Corp. (FKWL) has filed its 10-K report for the fiscal year ended June 30, 2026. The company is undergoing a strategic shift away from mobile hotspots towards fixed wireless routers and telecommunications modules due to declining demand for legacy products. Financials show a decrease in net sales to $36.5 million from $46.1 million in the previous year, accompanied by an increased net loss of $6.9 million compared to $0.14 million in the prior year. The company also detailed its ownership in subsidiaries Franklin Technology Inc. and Sigbeat Inc., and its workforce of 69 employees.
ECARX Holdings Inc. Q2 2026 Revenue $356.7M; Net Loss Narrows to $21M
ECARX Holdings Inc. reported a 10.3% increase in total revenues to US$356.7 million for the first six months of 2026. The company saw a significant improvement in profitability, with gross profit rising 45.4% to US$72.7 million and the loss from operations narrowing substantially to US$19.2 million. Adjusted EBITDA turned positive at US$4.5 million. Despite these improvements, the company continues to face challenges related to liquidity and has substantial doubt about its ability to continue as a going concern, outlining several plans to secure additional financing and reduce expenses.
Lifecore Biomedical to be Acquired by Webster Equity Partners for up to $663.7M
Lifecore Biomedical, Inc. has entered into a definitive agreement to be acquired by Webster Equity Partners for up to $663.7 million. Common stockholders will receive $6.28 per share in cash at closing, along with a contingent value right (CVR) per share. These CVRs provide the potential for additional cash payments up to an aggregate of $160 million, contingent upon achieving specific performance milestones in 2028, 2029, and 2030. The transaction, valued at up to $9.67 per common equivalent share assuming full CVR payments, is expected to close by the end of the fourth quarter of 2026, pending customary closing conditions including stockholder and regulatory approvals. Following the acquisition, Lifecore's common stock will be delisted from the Nasdaq.
MakeMyTrip Ltd: All Shareholder Resolutions Approved at AGM
MakeMyTrip Limited announced that its annual shareholders' meeting for the fiscal year 2026 was held on September 28, 2026. The company confirmed that all resolutions presented to the shareholders during the meeting were duly approved and passed.
Cycurion Projects $843K 2026 Revenue; Awaits Nasdaq Decision
Cycurion, Inc. announced that closed public safety engagements are forecast to generate approximately $843,028 in revenue during 2026, with a CAD administration position having a projected 10-year value of $3.43 million CAD. The company is also developing new cyber products and continuing legal actions related to past unauthorized press releases and false statements. Cycurion's stock remains listed on Nasdaq as it awaits a final decision from the Nasdaq Hearings Panel regarding its appeal of a delisting determination. Additionally, the company terminated an Equity Purchase Agreement with Yield Point NY LLC.
Bold Eagle to Combine with Cyber Intelligence Firm REDLattice for $1.25B
Bold Eagle Acquisition Corp. (BEAG) announced a definitive agreement to combine with REDL Intermediate Holdings, LLC (REDLattice), a provider of cyber intelligence platforms for government and defense customers. The transaction values REDLattice at a pre-money enterprise value of $1.25 billion and is expected to provide up to approximately $610 million in gross proceeds. REDLattice reported $267 million in revenue for the twelve months ended June 30, 2026, with a 29% year-over-year growth. The deal includes $335 million in committed capital from institutional investors, including convertible notes and a common stock PIPE.
Adicet Bio: Prula-cel Shows Positive SLE/LN Phase 1 Data
Adicet Bio announced positive safety and efficacy data from its Prula-cel Phase 1 study in patients with systemic lupus erythematosus (SLE) with or without lupus nephritis (LN). The data showed high rates of immunosuppressant-free responses, with 50% of lupus nephritis patients achieving complete renal response and 54% of evaluable patients achieving DORIS remission at 12 months. Prula-cel demonstrated a favorable safety profile with no severe cytokine release syndrome (CRS), immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS), or immune effector cell-associated neurotoxicity syndrome (ICANS). The company plans to initiate pivotal study start-up activities in Q4 2026.
News Corp Updates $1B Stock Repurchase Program; $498.9M Used
News Corp provided an update on its ongoing $1 billion stock repurchase program, authorized on July 15, 2025. As of September 28, 2026, the company has utilized approximately $498.9 million of the authorized amount for repurchasing Class A and Class B common stock. The filing details daily buy-back notifications for September 25, 2026, including the number of shares and total consideration paid for both classes of stock. The program's stated purpose is to enhance shareholder value.
Inventiva H1 2026 Net Loss €69.5M; Refinancing Completed
Inventiva S.A. reported its financial results for the first half of 2026, showing a reduced net loss of €69.5 million compared to €175.9 million in the prior year period. Revenues significantly decreased to €20 thousand from €4.5 million. The company also detailed a comprehensive refinancing transaction completed in June 2026, which included an equity offering and debt financing, and expects this to fund operations until the end of Q2 2027. Key clinical trial updates include the expectation of topline results for the Phase 3 NATiV3 trial in Q4 2026.